Angion Biomedica Corp. ANGN
$ 1.0
2.04%
Quarterly report 2024-Q3
added 11-13-2024
Country |
USA |
IPO year |
2021 |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
- |
Employees in the company |
- |
Shares |
5.06 M |
Market Cap[1] |
$ 30.1 M |
EBITDA (LTM) |
$ -32.5 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.